Stocks · News reference
CDT Equity shares are trading lower after the company announced that, following share issuances and warrant exercises, it had 13.7 million shares outstanding, valuing the firm at about $23 million despite resolving Nasdaq deficiencies.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
CDT Equity Announces 1-For-25 Reverse Stock Split, Effective September 28
CDT Equity shares are trading lower. The company announced a partnership with QIMA Life Sciences to explore the potential of several of CDT’s assets in autoimmune skin diseases.
CDT Equity Partners With QIMA Life Sciences To Develop Several Of The Company's Autoimmune Skin Disease Assets, Including Novel Tapinarof Combinations In Psoriasis And Vitiligo
CDT plans to leverage QIMA’s unique access to human skin from both healthy donors and patients. The use of patient tissue offers the most clinically relevant data possible, providing rapid translation to clinic and